Patent details
EP4046995 Title: 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS
Basic Information
- Publication number:
- EP4046995
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP221665383
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS
- French Title of Invention:
- COMPOSÉS ISOCHROMANYLES 1-HÉTÉROCYCLYLES ET ANALOGUES POUR LE TRAITEMENT DE TROUBLES DU SNC
- German Title of Invention:
- 1-HETEROCYCLYL-ISOCHROMANYL-VERBINDUNGEN UND ANALOGA ZUM BEHANDELN VON ZNS-STÖRUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 13/10/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 19/10/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 13/09/2023
- Unitary Effect Registration Date:
- 19/10/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 11/02/2016
- Grant date:
- 13/09/2023
- EP Publication Date:
- 24/08/2022
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/09/2023
- EP B1 Publication Date:
- 13/09/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/02/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/09/2023
- Name:
- PGI Drug Discovery LLC
- Address:
- 215 College Road, Paramus, NJ 07652, United States (US)
- Name:
- Sunovion Pharmaceuticals Inc.
- Address:
- 84 Waterford Drive, Marlborough, MA 01752-7010, United States (US)
Inventor
1
- Name:
- ALEXANDROV, Vadim
- Address:
- United States (US)
2
- Name:
- XIE, Linghong
- Address:
- United States (US)
3
- Name:
- POWELL, Noel Aaron
- Address:
- United States (US)
4
- Name:
- HANANIA, Taleen G.
- Address:
- United States (US)
5
- Name:
- JONES, Philip Glyn
- Address:
- United States (US)
6
- Name:
- SPEAR, Kerry L.
- Address:
- United States (US)
Priority
- Priority Number:
- 201562115064 P
- Priority Date:
- 11/02/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07D 405/14; C07D 413/14; C07D 405/04; C07D 493/04; A61K 31/353; A61K 31/4025; A61P 25/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202347
- Publication date:
- 22/11/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202347
- Publication date:
- 22/11/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|